BerandaEH3 • FRA
add
Amarin Corporation PLC
Tutup sebelumnya
€10,30
Rentang hari
€10,30 - €11,10
Rentang tahun
€7,16 - €11,10
Kapitalisasi pasar
263,54 jt USD
Volume Rata-Rata
9,00
Rasio P/E
-
Hasil dividen
-
Dalam berita
Keuangan
Laporan Pendapatan
Pendapatan
Laba bersih
| (USD) | Mar 2025info | Perubahan Y/Y |
|---|---|---|
Pendapatan | 42,02 jt | -25,66% |
Biaya operasional | 41,88 jt | -7,92% |
Laba bersih | -15,70 jt | -57,71% |
Margin laba bersih | -37,36 | -112,15% |
Penghasilan per saham | -0,40 | -100,00% |
EBITDA | -16,02 jt | -24,99% |
Tarif pajak efektif | -15,16% | — |
Neraca
Total aset
Total liabilitas
| (USD) | Mar 2025info | Perubahan Y/Y |
|---|---|---|
Investasi tunai jangka pdk | 281,79 jt | -8,56% |
Total aset | 655,68 jt | -17,00% |
Total liabilitas | 181,99 jt | -25,44% |
Total ekuitas | 473,69 jt | — |
Saham yang beredar | 20,71 jt | — |
Harga terhadap nilai buku | 0,45 | — |
Tingkat pengembalian aset | -6,25% | — |
Tingkat pengembalian modal | -8,55% | — |
Arus Kas
Perubahan kas bersih
| (USD) | Mar 2025info | Perubahan Y/Y |
|---|---|---|
Laba bersih | -15,70 jt | -57,71% |
Kas dari operasi | -12,46 jt | 1,13% |
Kas dari investasi | 12,06 jt | -57,99% |
Kas dari pembiayaan | -1,12 jt | 21,53% |
Perubahan kas bersih | -1,51 jt | -110,30% |
Arus kas bebas | -13,50 jt | 7,29% |
Tentang
Amarin Corporation is an Irish-American biopharmaceutical company founded in 1993 and headquartered in Dublin, Ireland and Bridgewater, New Jersey. The company develops and markets medicines for the treatment of cardiovascular disease. It has developed the drug Vascepa, a prescription grade omega-3 fatty acid.
In July 2012, their lead-candidate drug named Vascepa received FDA-approval, competing against GlaxoSmithKline's Lovaza. Wikipedia
Didirikan
1 Mar 1989
Kantor pusat
Situs
Karyawan
275
